Evidence map›Paper›PMID 27145926›Full record

ArticleAmerican journal of reproductive immunology (New York, N.Y. : 1989)2016

Longitudinal Assessment of Systemic and Genital Tract Inflammatory Markers and Endogenous Genital Tract E. coli Inhibitory Activity in HIV-Infected and Uninfected Women.

Marla J Keller, Aileen P McGinn, Yungtai Lo, Ashley Huber, Lilia Espinoza, Howard Minkoff, Christine Colie, Marek J Nowicki, Gypsyamber D'Souza, Kathryn Anastos

Open access · greenAbstract read
In one paragraph

Article in American journal of reproductive immunology (New York, N.Y. : 1989), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Marla J KellerAlbert Einstein College of Medicine, Bronx, NY, USA.
Aileen P McGinnAlbert Einstein College of Medicine, Bronx, NY, USA.
Yungtai LoAlbert Einstein College of Medicine, Bronx, NY, USA.
Ashley HuberAlbert Einstein College of Medicine, Bronx, NY, USA.
Lilia EspinozaAlbert Einstein College of Medicine, Bronx, NY, USA.
Howard MinkoffMaimonides Medical Center, Brooklyn, NY, USA.
Christine ColieGeorgetown University Medical Center, Washington, DC, USA.
Marek J NowickiUniversity of Southern California, Los Angeles, CA, USA.
Gypsyamber D'SouzaJohns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kathryn AnastosAlbert Einstein College of Medicine, Bronx, NY, USA.
Albert Einstein College of Medicine · USGeorgetown University Medical Center · USJohns Hopkins University · USMaimonides Medical Center · USUniversity of Southern California · US

Funding

Women's Interagency HIV Study (WIHS-V)U01AI035004 · NIAID · MONTEFIORE MEDICAL CENTER (BRONX, NY) · PI ANASTOS, KATHRYN M., SHARMA, ANJALI · 1993 to 2018
$65.7M
Women's Interagency HIV Study (WIHS) IIIU01AI031834 · NIAID · SUNY DOWNSTATE MEDICAL CENTER · PI GUSTAFSON, DEBORAH R., MINKOFF, HOWARD · 1998 to 2018
$53.5M
WOMEN'S INTERAGENCY HIV STUDY (WIHS) ORGANIZATION AND MANAGEMENTU01AI034994 · NIAID · GEORGETOWN UNIVERSITY · PI KASSAYE, SEBLE G · 1993 to 2018
$52.0M
WOMENS INTERAGENCY HIV STUDY (WIHS)U01HD032632 · NICHD · UNIVERSITY OF SOUTHERN CALIFORNIA · PI MILAM, JOEL E · 1994 to 2012
$42.0M
WIHS DATA MANAGEMENT AND ANALYSIS CENTER(WDMAC)U01AI042590 · NIAID · JOHNS HOPKINS UNIVERSITY · PI GANGE, STEPHEN J, GOLUB, ELIZABETH T · 1998 to 2018
$38.4M
Core-010UL1TR001073 · NCATS · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI KELLER, MARLA J, SHAMOON, HARRY · 2013 to 2017
$21.3M
Immunology/Pathology CoreP30AI051519 · NIAID · YESHIVA UNIVERSITY · PI GOLDSTEIN, HARRIS · 2003 to 2013
$18.6M
NCATS NIH HHS UL1 TR001073NIAID NIH HHS P30 AI051519NIAID NIH HHS U01 AI031834NIAID NIH HHS U01 AI034994NIAID NIH HHS U01 AI035004NIAID NIH HHS U01 AI042590NICHD NIH HHS U01 HD032632
6 · The paper itself

Abstract

problemStability over time of systemic and mucosal immunity and their associations with bacterial vaginosis (BV) and HIV-specific parameters were assessed. METHOD OF STUDY: Immune mediators and HIV viral load in plasma and cervicovaginal lavage (CVL), E. coli inhibition, and Nugent score were measured at three semiannual visits among 94 participants in the Women's Interagency HIV Study. Mixed models identified the factors associated with immune mediators.

resultsThere was higher E. coli inhibition and lower inflammation over time in the genital tract and systemically. BV was consistently associated with higher CVL inflammatory mediators and lower CVL E. coli inhibition. HIV-infected women with higher CD4 counts had lower systemic and genital inflammatory mediators, and genital HIV shedding was associated with higher CVL inflammatory mediators. Use of antiretroviral therapy (ART) was associated with lower plasma and CVL mediators, but higher E. coli inhibition.

conclusionHIV and BV are linked to inflammation, and ART may be associated with improved vaginal health.

Indexed as

AdultAnti-Retroviral AgentsCD4-Positive T-LymphocytesCell Growth ProcessesCytokinesEscherichia coliFemaleFollow-Up StudiesGenitalia, FemaleHIVHIV InfectionsHumansImmunity, MucosalInflammationInflammation MediatorsMiddle AgedAnti-Retroviral AgentsCytokinesInflammation MediatorsBacterial vaginosisgenital tractHIVinflammationmucosal immunity

Identifiers

PMID27145926
PMCPMC4877270
OpenAlexW2346785107

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.